3 Things to Expect in Illumina's Q3 Earnings Results
A quick look at Illumina (NASDAQ: ILMN) stock's performance is all you need to know how the company's first two quarters in 2017 went. Illumina's share price has soared 60% so far this year after the gene-sequencing leader beat revenue guidance in the first quarter and blew past both revenue and earnings guidance in the second quarter.
Investors will find out if Illumina's momentum will continue next week when the company announces its third-quarter earnings results. Here are three things to expect in those results.
Image source: Illumina.
Source: Fool.com
Illumina Inc. Aktie
108,18 €
-4,59 %
Die Community bevorzugt Illumina Inc., mit deutlich mehr Buy- (27) als Sell-Einschätzungen (4).
Ein Kursziel von 162 € für Illumina Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 108.18 € bedeuten.
